ID   HBCC/HL-004
AC   CVCL_B6Z7
SY   Human Breast Cancer Cell/HL-004
DR   CCRID; 4201PAT-CCTCC00664
DR   Wikidata; Q111733333
RX   Patent=CN107988160A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201535.
CC   Population: Chinese.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): Patent=CN107988160A
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 13,16
ST   D12S391: 18,21
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D18S51: 17,18
ST   D19S433: 15,16
ST   D21S11: 30
ST   D2S1338: 22,23,28
ST   D2S441: 10
ST   D3S1358: 15,16
ST   D5S818: 7,11
ST   D6S1043: 17,19
ST   D7S820: 8,11
ST   D8S1179: 11,13
ST   FGA: 22,24
ST   Penta D: 12,13
ST   Penta E: 11,13
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
RX   Patent=CN107988160A;
RA   Li H., Ye L.-N., Wang L., Chen Y., Wu X.-T.;
RT   "Human breast cancer cell and its primary it is separately cultured
RT   and secondary culture method and purposes.";
RL   Patent number CN107988160A, 04-May-2018.
//